Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine XR for Depression After Spinal Cord Injury
NCT00592384Phase 4Completed
- Sponsor
- University of Washington
- Start
- Jul 2007
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) and persistent depressive disorder (PDD) comparing Venlafaxine XR with Placebo (2 arms). Primary endpoints: Hamilton Depression Rating Scale-17 at 12 weeks and Hamilton Depression Rating Scale-Maier Subscale at 12 weeks. Started Jul 2007; status: completed.
02
Drugs
venlafaxine
03
Conditions
major depressive disorder (MDD)persistent depressive disorder (PDD)
Beyond the preview
Go deeper on NCT00592384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00592384.